Sign in

CIK 0001297184 · Large accelerated filer

Amphastar Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
330702205
Phone
909-980-9484
Business address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
  1. 4 Shares withheld for taxes CFO, SVP & Treasurer gave up 1,823 shares (to pay taxes)
  2. 4 Shares withheld for taxes President and General Counsel gave up 10,652 shares (to pay taxes)
  3. 4 Shares withheld for taxes CEO & Chief Scientific Officer gave up 65,254 shares (to pay taxes)
  4. 4 Shares withheld for taxes EVP, Production Center gave up 1,248 shares (to pay taxes)
  5. 4 Shares withheld for taxes EVP, QA & Regulatory Affairs gave up 1,194 shares (to pay taxes)
  6. 4 Shares withheld for taxes CFO, SVP & Treasurer gave up 3,704 shares (to pay taxes)
  7. 4 Shares withheld for taxes President and General Counsel gave up 7,049 shares (to pay taxes)
  8. 4 Shares withheld for taxes CEO & Chief Scientific Officer gave up 33,059 shares (to pay taxes)
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 10-K Report Annual Report
  11. 8-K Event Results of operations
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G Stake Amended Statement of Ownership
  14. 4 Open-market sale Director sold 400 shares at $18.61 ($7,444)
  15. 8-K Event Other events
  16. 4 Open-market sale EVP, QA & Regulatory Affairs sold 2,940 shares at $20.51 ($60,287)
  17. 4 Open-market sale EVP, Production Center sold 61 shares at $20.70 ($1,262)
  18. 4 Open-market sale Director sold 400 shares at $20.26 ($8,104)
  19. 4 Open-market sale President and General Counsel sold 26,335 shares at an average $20.48 ($539,258)
  20. 4 Open-market sale Director sold 37,994 shares at an average $20.65 ($784,680)

Page 38 of 48 · 958 filings